A feedback loop sustaining neutrophil extracellular trap formation involves S100 proteins, histones, TLR2 and RAGE, and is restrained by albumin - Scorecard - MDSpire

A feedback loop sustaining neutrophil extracellular trap formation involves S100 proteins, histones, TLR2 and RAGE, and is restrained by albumin

  • By

  • Vanessa de Carvalho Oliveira

  • Matthew Mazur

  • Patrick P. McDonald

  • June 1, 2026

  • 0 min

Share

Clinical Scorecard: A regulatory loop promoting the formation of neutrophil extracellular traps involves S100 proteins, histones, TLR2, and RAGE, while albumin serves to limit this process.

At a Glance

CategoryDetail
ConditionNeutrophil extracellular trap (NET) formation
Key MechanismsInvolvement of S100 proteins, histones, RAGE, and TLR2 in NET generation; albumin as a physiological brake.
Target PopulationPatients with infections, inflammatory diseases, and autoimmune disorders.
Care SettingClinical and research settings focused on immunology and pathology.

Key Highlights

  • S100 proteins and histones are identified as key endogenous NET inducers.
  • NET formation is mediated by RAGE and TLR2 receptors.
  • Human serum albumin (HSA) sequesters NET inducers, preventing excessive NET formation.
  • NETs play a dual role in antimicrobial defense and tissue damage.
  • Regulation of NET formation is critical to prevent pathologies associated with excessive NETs.

Guideline-Based Recommendations

Diagnosis

  • Assess NET formation in patients with infections and inflammatory conditions.

Management

  • Consider targeting RAGE and TLR2 pathways in therapeutic strategies.

Monitoring & Follow-up

  • Monitor levels of S100 proteins and histones in patients at risk of excessive NET formation.

Risks

  • Excessive NET formation can lead to tissue damage and contribute to thrombus formation.

Patient & Prescribing Data

Patients with conditions associated with dysregulated NET formation.

Albumin administration may help regulate NET formation in at-risk patients.

Clinical Best Practices

  • Implement strategies to monitor and regulate NET formation in clinical settings.
  • Utilize albumin as a potential therapeutic agent to limit excessive NET generation.

Related Resources & Content

Original Source(s)

Related Content